Literature DB >> 23726533

Expanding the paradigm of eosinophilic esophagitis: mast cells and IL-9.

Yui-Hsi Wang, Simon P Hogan, Patricia C Fulkerson, J Pablo Abonia, Marc E Rothenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23726533      PMCID： PMC4115361          DOI： 10.1016/j.jaci.2013.04.010

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  23 in total

Review 1.  Pathophysiology of bronchial smooth muscle remodelling in asthma.

Authors:  I Bara; A Ozier; J-M Tunon de Lara; R Marthan; P Berger
Journal:  Eur Respir J       Date:  2010-11       Impact factor: 16.671

2.  Local hypersensitivity reaction in transgenic mice with squamous epithelial IL-5 overexpression provides a novel model of eosinophilic oesophagitis.

Authors:  Joanne C Masterson; Eóin N McNamee; Lindsay Hosford; Kelley E Capocelli; Joseph Ruybal; Sophie A Fillon; Alfred D Doyle; Holger K Eltzschig; Anil K Rustgi; Cheryl A Protheroe; Nancy A Lee; James J Lee; Glenn T Furuta
Journal:  Gut       Date:  2012-11-17       Impact factor: 23.059

3.  Anti-IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis.

Authors:  Iris M Otani; Arjun A Anilkumar; Robert O Newbury; Monica Bhagat; Lisa Y Beppu; Ranjan Dohil; David H Broide; Seema S Aceves
Journal:  J Allergy Clin Immunol       Date:  2013-04-25       Impact factor: 10.793

4.  Working with the US Food and Drug Administration: progress and timelines in understanding and treating patients with eosinophilic esophagitis.

Authors:  Marc E Rothenberg; Seema Aceves; Peter A Bonis; Margaret H Collins; Nirmala Gonsalves; Sandeep K Gupta; Ikuo Hirano; Chris A Liacouras; Phil E Putnam; Jonathan M Spergel; Alex Straumann; Barry K Wershil; Glenn T Furuta
Journal:  J Allergy Clin Immunol       Date:  2012-09       Impact factor: 10.793

5.  A striking local esophageal cytokine expression profile in eosinophilic esophagitis.

Authors:  Carine Blanchard; Emily M Stucke; Beatriz Rodriguez-Jimenez; Karen Burwinkel; Margaret H Collins; Annette Ahrens; Eileen S Alexander; Bridget K Buckmeier Butz; Sean C Jameson; Ajay Kaul; James P Franciosi; Jonathan P Kushner; Philip E Putnam; J Pablo Abonia; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2011-01       Impact factor: 10.793

6.  Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis.

Authors:  Miguel L Stein; Margaret H Collins; Joyce M Villanueva; Jonathan P Kushner; Philip E Putnam; Bridget K Buckmeier; Alexandra H Filipovich; Amal H Assa'ad; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2006-11-07       Impact factor: 10.793

Review 7.  Eosinophilic esophagitis: updated consensus recommendations for children and adults.

Authors:  Chris A Liacouras; Glenn T Furuta; Ikuo Hirano; Dan Atkins; Stephen E Attwood; Peter A Bonis; A Wesley Burks; Mirna Chehade; Margaret H Collins; Evan S Dellon; Ranjan Dohil; Gary W Falk; Nirmala Gonsalves; Sandeep K Gupta; David A Katzka; Alfredo J Lucendo; Jonathan E Markowitz; Richard J Noel; Robert D Odze; Philip E Putnam; Joel E Richter; Yvonne Romero; Eduardo Ruchelli; Hugh A Sampson; Alain Schoepfer; Nicholas J Shaheen; Scott H Sicherer; Stuart Spechler; Jonathan M Spergel; Alex Straumann; Barry K Wershil; Marc E Rothenberg; Seema S Aceves
Journal:  J Allergy Clin Immunol       Date:  2011-04-07       Impact factor: 10.793

8.  Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism.

Authors:  Anil Mishra; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2003-11       Impact factor: 22.682

9.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

Authors:  Marc Veldhoen; Richard J Hocking; Christopher J Atkins; Richard M Locksley; Brigitta Stockinger
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

10.  An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation.

Authors:  Christoph Wilhelm; Keiji Hirota; Benjamin Stieglitz; Jacques Van Snick; Mauro Tolaini; Katharina Lahl; Tim Sparwasser; Helena Helmby; Brigitta Stockinger
Journal:  Nat Immunol       Date:  2011-10-09       Impact factor: 25.606
View more
  5 in total

1.  Elevated Tryptase in EoE Is an Independent Phenomenon Associated with Extra-Esophageal Symptoms.

Authors:  Geeta R Kutty; Erinn Downs-Kelly; Hilda T Crispin; Kathryn A Peterson
Journal:  Dig Dis Sci       Date:  2018-09-28       Impact factor: 3.199

2.  Mast Cell Infiltration Is Associated With Persistent Symptoms and Endoscopic Abnormalities Despite Resolution of Eosinophilia in Pediatric Eosinophilic Esophagitis.

Authors:  Scott M Bolton; Amir F Kagalwalla; Nicoleta C Arva; Ming-Yu Wang; Katie Amsden; Hector Melin-Aldana; Evan S Dellon; Paul J Bryce; Barry K Wershil; Joshua B Wechsler
Journal:  Am J Gastroenterol       Date:  2020-02       Impact factor: 12.045

3.  A pilot study of omalizumab in eosinophilic esophagitis.

Authors:  Denise Loizou; Benjamin Enav; Edina Komlodi-Pasztor; Pamela Hider; Julie Kim-Chang; Laura Noonan; Tabitha Taber; Suhasini Kaushal; Renuka Limgala; Margaret Brown; Raavi Gupta; Nader Balba; Ozlem Goker-Alpan; Amer Khojah; Oral Alpan
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

Review 4.  Pathogenesis of Eosinophilic Esophagitis: A Comprehensive Review of the Genetic and Molecular Aspects.

Authors:  Seohyun Ryu; Keum Hwa Lee; Kalthoum Tizaoui; Salvatore Terrazzino; Sarah Cargnin; Maria Effenberger; Jae Il Shin; Andreas Kronbichler
Journal:  Int J Mol Sci       Date:  2020-09-30       Impact factor: 5.923

5.  Mast Cell Activation in the Systemic Sclerosis Esophagus.

Authors:  Kevin Tom; Bhaven K Mehta; Aileen Hoffmann; Kathleen Aren; Mary Carns; Jungwha Lee; Viktor Martyanov; Dillon Popovich; Noelle Kosarek; Tammara Wood; Darren Brenner; Dustin A Carlson; Lorena Ostilla; Emma Willcocks; Paul Bryce; Joshua B Wechsler; Michael L Whitfield; Monique Hinchcliff
Journal:  J Scleroderma Relat Disord       Date:  2020-07-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.